Показано 0 из 0
Дата |
---|
14:18 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
46.10
|
46.90
|
44.50
|
44.50
|
45.20
|
45.20
|
|
|
|
|
44.30
|
45.30
|
47.50
|
44.30
|
47.50
|
44.30
|
|
|
|
|
47.20
|
47.90
|
44.60
|
43.30
|
46.80
|
46.80
|
|
|
|
|
42.90
|
44.10
|
40.40
|
40.40
|
41.90
|
41.90
|
|
|
|
|
40.10
|
41.00
|
39.90
|
39.80
|
40.20
|
40.20
|
|
|
|
|
39.20
|
40.20
|
40.30
|
39.60
|
40.30
|
39.60
|
|
|
|
|
40.40
|
41.20
|
38.70
|
38.40
|
40.70
|
40.60
|
|
|
8 020.00
|
5.00
|
38.40
|
39.30
|
39.20
|
38.30
|
39.20
|
38.40
|
|
|
|
|
37.10
|
37.90
|
37.20
|
37.00
|
37.60
|
37.00
|
|
|
|
|
36.40
|
37.20
|
38.60
|
36.50
|
39.50
|
36.50
|
|
|
|
|
Gubra is specialized in pre-clinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases. Gubra’s activities are focused on the early stages of drug development and are organised in two business areas - CRO Services and Discovery & Partnerships (D&P).